MARKET

AXSM

AXSM

Axsome Therapeut
NASDAQ
72.16
+1.89
+2.68%
Opening 13:24 01/30 EST
OPEN
71.35
PREV CLOSE
70.27
HIGH
74.13
LOW
71.16
VOLUME
508.22K
TURNOVER
19.58M
52 WEEK HIGH
82.00
52 WEEK LOW
20.63
MARKET CAP
3.13B
P/E (TTM)
-17.7333
1D
5D
1M
3M
1Y
5Y
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Ventyx Biosciences (VTYX)
TipRanks · 3d ago
Healthcare Outlook 2023
Seeking Alpha · 01/23 15:02
Axsome Therapeutics (AXSM) Gets a Buy from Mizuho Securities
TipRanks · 01/20 14:15
Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish
Seeking Alpha · 01/09 14:55
BRIEF-Axsome Therapeutics Enters Into Third Amendment To Its Loan And Security Agreement With Hercules Capital
Reuters · 01/09 13:29
Mizuho Securities Keeps Their Buy Rating on Axsome Therapeutics (AXSM)
TipRanks · 01/06 14:05
Piper Sandler Initiates Coverage On Axsome Therapeutics with Neutral Rating, Announces Price Target of $75
Benzinga · 01/05 11:14
Piper Sandler Starts Axsome Therapeutics at Neutral With $75 Price Target
Piper Sandler Starts Axsome Therapeutics at Neutral With $75 Price Target
MT Newswires · 01/05 08:02
More
About AXSM
Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is developing novel therapies for central nervous system (CNS) disorders for which there are limited treatment options. It is developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. The Company's CNS portfolio includes four product candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14. AXS-05 is being developed for the treatment of major depressive disorder (MDD), Alzheimer's disease agitation (AD agitation), and smoking cessation. AXS-07 is a novel, oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine. AXS-12 is an investigational medicine in development for the treatment of narcolepsy. The Company also provides Sunosi, which is dual-acting dopamine and norepinephrine reuptake inhibitor indicated to improve wakefulness in adult patients.

Webull offers kinds of Axsome Therapeutics Inc stock information, including NASDAQ:AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.